Evercore ISI Group Initiates Coverage On Astria Therapeutics With Outperform Rating, Announces Price Target of $18
Evercore ISI Group Initiates Coverage On Astria Therapeutics With Outperform Rating, Announces Price Target of $18
Evercore ISI Group以跑赢大盘的评级开始对Astria Therapeutics进行报道，宣布目标股价为18美元
Evercore ISI Group analyst Liisa Bayko initiates coverage on Astria Therapeutics (NASDAQ:ATXS) with a Outperform rating and announces Price Target of $18.
Evercore ISI Group分析师Liisa Bayko以跑赢大盘的评级开始对Astria Therapeutics（纳斯达克股票代码：ATXS）进行报道，并宣布目标股价为18美元。